Biotechnology

Shrimp
20 June 2024   Magistrate stand-in not authorised to answer jury questions, says eleventh circuit in precedential opinion | Florida judge left to catch flight before verdict given | Dispute between shrimp breeders concerns “unique” breeding method.

Latest Features

Biotechnology
As artificial intelligence creates a complex legal landscape for healthcare and medtech, Janine Swarbrick of HGF explores two case studies that shed light on how to claim an AI invention.
Biotechnology
It is critical that the emerging field of personalised medicine receives appropriate patent protection, explain Joel Coles and Theo Cooper of Powell Gilbert.
Biotechnology
Agreeing to a dispute resolution mechanism in an international joint venture requires forward thinking, say Jens Petry and Tom Gassmann, Squire Patton Boggs.
Big Pharma
Kerri-Ann Limbeek, trial lead for Ravgen, tells Sarah Speight that a compelling narrative was key to winning the case against their larger rival.
Biotechnology
Despite the clamour for guidance, applicants, attorneys, and lawyers may be in for a frustrating wait before the UK updates AI protections, says Rebecca Lawrence of DLA Piper.
Biotechnology
Mark Hatch-Miller, who led the trial team at Susman for Globus, tells Sarah Speight how this spinal implant patent dispute, brought by a Johns Hopkins neurosurgeon, was a “heavy lift”.
Biotechnology
Patent applications need to offer the full picture when it comes to scientific research, finds Marisa Woutersen at LSPN Europe.
Americas
An ambiguous decision by the Supreme Court has paved the way for frivolous petitions for compensation and clarity is needed, say Daniel Sanchez and Karla Olvera of Olivares.
All features


More News

21 May 2024   ARP maintained rejection of two claims of Xencor’s antibodies patent application | Panel clarified specification for means-plus-function claim limitations.
21 May 2024   Despite attempts by Pfizer and BioNTech to invalidate the patent, the ruling strengthens Moderna’s position in ongoing global litigation | Pfizer is considering an appeal, while BioNTech remains steadfast in defending its innovations.
16 May 2024   Puritan Medical argued it had immunity under PREP Act in patent suit | Fed Circ said the district court had not conclusively determined any issue.
9 May 2024   Biotech firm to ask Munich court to permanently lift injunction on CosMx products following ruling | Judgment comes a day after acquisition by Bruker was finalised.
7 May 2024   Two-day event in Boston brings together leading in-house patent counsel | Regeneron, USPTO, the Broad Institute and Novartis among attendees I Agenda includes the UPC, patent strategies, and multijurisdictional patent litigation | Registrations for LSPN Fall now open.
2 May 2024   Ahead of her panel discussion at LSPN North America, BioNTech’s patent counsel, shares insights into her role and ensuring innovations meet the criteria of novelty and nonobviousness.
2 May 2024   Former senior legal advisor at USPTO brings wealth of life sciences experience | Move represents transition back into private practice after two decades.
More news